DP CD8 TIL
2023000082
Phase 1 mab active
Quick answer
DP CD8 TIL for HNSCC is a Phase 1 program (mab) at Phio Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Phio Pharmaceuticals
- Indication
- HNSCC
- Phase
- Phase 1
- Modality
- mab
- Status
- active